CONCERTO II,CONSULTA,MAXIMO II,PROTECTA AND PROTECTA XT CRT-DS
FDA premarket approval P010031/S474 · decided 2014-12-12
Approval details
- PMA number
- P010031
- Supplement
- S474
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONCERTO II,CONSULTA,MAXIMO II,PROTECTA AND PROTECTA XT CRT-DS
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-11-24
- Decision date
- 2014-12-12
- Days to decision
- 18 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- UPDATE TO THE PRE-PULSE OPEN CIRCUIT TEST LIMITS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.